A Regional System of Stroke Care Provides Thrombolytic Outcomes Comparable With the NINDS Stroke Trial

Annals of Emergency Medicine

Volumn 54, Issue 3, 2009, Pages 319-327

  LaMonte, Marian P ^a   Bahouth, Mona N ^b   Magder, Laurence S ^a   Alcorta, Richard L ^c   Bass, Robert R ^c   Browne, Brian J ^a   Floccare, Douglas J ^a,c   Gaasch, Wade R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

^c Maryland Institute for Emergency Medical Services Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CHILD; CLINICAL TRIAL; COMMUNITY HOSPITAL; COMPARATIVE STUDY; CONSULTATION; DRUG SAFETY; EMERGENCY MEDICINE; FEMALE; FIBRINOLYTIC THERAPY; HEALTH CARE ACCESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MORTALITY; PATIENT CARE; PRIORITY JOURNAL; RANKIN SCALE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DELAWARE; DISTRICT OF COLUMBIA; EMERGENCY MEDICAL SERVICES; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MARYLAND; MIDDLE AGED; PENNSYLVANIA; PROGRAM EVALUATION; RECOVERY OF FUNCTION; REGIONAL MEDICAL PROGRAMS; STROKE; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; WEST VIRGINIA; YOUNG ADULT;

EID: 68649127553     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2008.09.022     Document Type: Article

References (21)

1. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
2. Akins P.T., Delemos C., Wentworth D., et al. Can emergency department physicians safely and effectively initiate thrombolysis for acute ischemic stroke?. Neurology 55 (2000) 1801-1805
3. Egan R., Lutsep H.L., Clark W.M., et al. Open label tissue plasminogen activator for stroke: the Oregon experience. J Stroke Cerebrovasc Dis 8 (1999) 287-290
4. Koennecke H., Nohr R., Leistner S., et al. Intravenous tPA for ischemic stroke team performance over time, safety, and efficacy in a single center, 2-year experience. Stroke 32 (2001) 1074-1078
5. Szoeke C.E., Parsons M.W., Butcher K.S., et al. Acute stroke thrombolysis with intravenous tissue plasminogen activator in an Australian tertiary hospital. Med J Aust 178 (2003) 324-328
6. Asimos A.W., Norton J., Price M.F., et al. Therapeutic yield and outcomes of a community teaching hospital code stroke protocol. Acad Emerg Med 11 (2004) 361-370
7. Katzan I.L., Furlan A.J., Lloyd L.E., et al. Use of tissue plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 283 (2000) 1151-1158
8. Albers G.W., Bates V.E., Clark W.M., et al. Intravenous tissue type plasminogen activator for treatment of acute stroke. The Standard Treatment With Alteplase to Reverse Stroke (STARS) Study. JAMA 289 (2000) 1145-1150
9. Wang D.Z., and Rose J.A. Treating acute stroke patients with IV tPA (OSF Network). Stroke 31 (2000) 77-81
10. Grotta J.C., Burgin W.S., El-Mitwalli A., et al. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000. Arch Neurol 58 (2001) 2009-2013
11. Lopez-Yunez A.M., Bruno A., Williams L.S., et al. Protocol violations in community-based rTPA stroke treatment are associated with symptomatic intracerebral hemorrhage. Stroke 32 (2001) 12-16
12. Katzan I.L., Hammer M.D., Furlan A.J., et al. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update. Stroke 34 (2003) 799-800
13. Hill M.D., and Buchan A.M. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 172 (2005) 1307-1312 10
14. Dick A.P., and Straka J. IV tPA for acute ischemic stroke: results of the first 101 patients in a community practice. Neurologist 11 (2005) 305-308
15. Deng Y.Z., Reeves M.J., Jacobs B.S., et al. IV tissue plasminogen activator use in acute stroke: experience from a statewide registry. Neurology 66 (2006) 306-312
16. LaMonte M.P., Bahouth M.N., Hu P., et al. Telemedicine for acute stroke: triumphs and pitfalls. Stroke 34 (2003) 725-728
17. Bahouth M.N., and LaMonte M.P. The role of an acute stroke nurse practitioner: practice outcomes [abstract]. Stroke 37 (2006) 746
18. Merino J.G., Lattimore S.U., and Warach S. Telephone assessment of stroke outcome is reliable. Stroke 36 (2005) 232-233
19. Gencheva E., Sloan M., Leurgans S., et al. Attrition and non-compliance in secondary stroke prevention trials. Neuroepidemiology 23 (2004) 61-66
20. LaMonte MP, Yarbrough KL, Bahouth MN, et al. Outcome of patients transported by air versus ground to a university stroke treatment center. Presented at: 32nd Annual Critical Care Congress; January 30, 2003; San Antonio, TX.
21. Alberts M.J., Latchaw R.E., Selman W.R., et al. Recommendations for comprehensive stroke centers: a consensus statement for the Brain Attack Coalition. Stroke 36 (2005) 1597-1618